|
||||||||
Regenerative medicine is loosely defined as "the application of cell-based therapies to human disease." The promise of regenerative medicine is the use of stem cells to treat and even cure a number of human diseases, including heart disease, diabetes, and numerous neurodegenerative diseases. Stem cell biology also is impacting current approaches to cancer biology, as many solid tumors are thought to have a stem cell origin. The focus of this seminar style course will be the status of the current science of stem cell biology (and by implication, somatic cell nuclear transfer technology - SCNT - cloning technology). During the first half of the quarter, we will cover the history and basic science and technology of stem cell biology, SCNT, and the prospectus on regenerative medicine from the National Institutes of Health. During the second half of the quarter, students will present their findings on a given topic of their choice, relating human disease to a cell-based therapy. In addition, a written paper on that topic will be required. Who can enroll? All CCS students are invited to attend, although some background in biology is optimal. Required Reading: All required reading will be from a syllabus of primary literature and review articles, popular press articles, and selected book chapter readings. These will be provided by the course instructor. There is no required textbook. 3 Units: Regular attendance, participation in discussions of required reading, and completion of a satisfactory paper and presentation. Instructor(s): Kathy Foltz Time(s): Fridays, 10:00-11:50 am Place(s): Marine Biotech Bldg. (Bldg. 555), Rm. 3103 << Back |
||||||||
|
||||||||